Pathophysiology, risk factors, and screening methods for prediabetes in women with polycystic ovary syndrome

References

• LegroRSArslanianSAEhrmannDADiagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guidelineJ Clin Endocrinol Metab201398124565459224151290
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop GroupRevised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertil Steril20048111925
   Web of Science ®Google Scholar
• Diamanti-KandarakisEDunaifAInsulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implicationsEndocr Rev2012336981103023065822
   PubMed Web of Science ®Google Scholar
• LimSSDaviesMJNormanRJMoranLJOverweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysisHum Reprod Update201218661863722767467
   PubMed Web of Science ®Google Scholar
• LegroRSObesity and PCOS: implications for diagnosis and treatmentSemin Reprod Med201230649650623074008
   PubMed Web of Science ®Google Scholar
• YildizBOKnochenhauerESAzzizRImpact of obesity on the risk for polycystic ovary syndromeJ Clin Endocrinol Metab200893116216817925334
   PubMed Web of Science ®Google Scholar
• LiangSJHsuCSTzengCRChenCHHsuMIClinical and biochemical presentation of polycystic ovary syndrome in women between the ages of 20 and 40Hum Reprod201126123443344921926412
   PubMed Web of Science ®Google Scholar
• LegroRSKunselmanARDodsonWCDunaifAPrevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected womenJ Clin Endocrinol Metab19998411651699920077
   PubMed Web of Science ®Google Scholar
• Luque-RamirezMAlpanesMEscobar-MorrealeHFThe determinants of insulin sensitivity, beta-cell function, and glucose tolerance are different in patients with polycystic ovary syndrome than in women who do not have hyperandrogenismFertil Steril20109462214222120097337
   PubMed Web of Science ®Google Scholar
• ManiHLevyMJDaviesMJDiabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort studyClin Endocrinol (Oxf)201378692693423046078
   PubMed Web of Science ®Google Scholar
• NormanRJMastersLMilnerCRWangJXDaviesMJRelative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndromeHum Reprod20011691995199811527911
   PubMed Web of Science ®Google Scholar
• LegroRSGnatukCLKunselmanARDunaifAChanges in glucose tolerance over time in women with polycystic ovary syndrome: a controlled studyJ Clin Endocrinol Metab20059063236324215797965
   PubMed Web of Science ®Google Scholar
• BoudreauxMYTalbottEOKipKEBrooksMMWitchelSFRisk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-upCurr Diab Rep200661778316522285
   PubMedGoogle Scholar
• DunaifASegalKRFutterweitWDobrjanskyAProfound peripheral insulin resistance, independent of obesity, in polycystic ovary syndromeDiabetes1989389116511742670645
   PubMed Web of Science ®Google Scholar
• EhrmannDAPolycystic ovary syndromeN Engl J Med2005352121223123615788499
   PubMed Web of Science ®Google Scholar
• Godoy-MatosAFVaismanFPedrosaAPFariasMLFMendoncaLMCPinheiroMFMCCentral-to-peripheral fat ratio, but not peripheral body fat, is related to insulin resistance and androgen markers in polycystic ovary syndromeGynecol Endocrinol2009251279379819905998
   PubMed Web of Science ®Google Scholar
• YildirimBSabirNKaleliBRelation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndromeFertil Steril20037961358136412798883
   PubMed Web of Science ®Google Scholar
• HuangZHManickamBRyvkinVPCOS is associated with increased CD11c expression and crown-like structures in adipose tissue and increased central abdominal fat depots independent of obesityJ Clin Endocrinol Metab2013981E17E2423118428
   PubMed Web of Science ®Google Scholar
• WeiHJYoungRKuoILLiawCMChiangHSYehCYPrevalence of insulin resistance and determination of risk factors for glucose intolerance in polycystic ovary syndrome: a cross-sectional study of Chinese infertility patientsFertil Steril20099151864186818565519
   PubMed Web of Science ®Google Scholar
• LeeHOhJYSungYAChungHChoWYThe prevalence and risk factors for glucose intolerance in young Korean women with polycystic ovary syndromeEndocrine200936232633219688613
   PubMed Web of Science ®Google Scholar
• Diamanti-KandarakisEBaillargeonJPIuornoMJJakubowiczDJNestlerJEA modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pillsJ Clin Endocrinol Metab20038851927193212727935
   PubMed Web of Science ®Google Scholar
• De PirroRForteFBertoliAGrecoAVLauroRChanges in insulin receptors during oral contraceptionJ Clin Endocrinol Metab198152129337451643
   PubMed Web of Science ®Google Scholar
• WatanabeRMAzenCGRoySPerlmanJABergmanRNDefects in carbohydrate metabolism in oral contraceptive users without apparent metabolic risk factorsJ Clin Endocrinol Metab1994795127712837962320
   PubMed Web of Science ®Google Scholar
• GodslandIFCrookDSimpsonRThe effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolismN Engl J Med199032320137513812146499
   PubMed Web of Science ®Google Scholar
• MeyerCMcGrathBPTeedeHJEffects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndromeDiabetes Care200730347147817327307
   PubMed Web of Science ®Google Scholar
• Morin-PapunenLCVauhkonenIKoivunenRMRuokonenAMartikainenHKTapanainenJSEndocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized studyJ Clin Endocrinol Metab20008593161316810999803
   PubMed Web of Science ®Google Scholar
• Morin-PapunenLVauhkonenIKoivunenRRuokonenAMartikainenHTapanainenJSMetformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized studyJ Clin Endocrinol Metab200388114815612519844
   PubMed Web of Science ®Google Scholar
• OrioFMuscogiuriGGiallauriaFOral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trialClin Endocrinol (Oxf) Epub2016524
   Web of Science ®Google Scholar
• AdenijiAAEssahPANestlerJECheangKIMetabolic effects of a commonly used combined hormonal oral contraceptive in women with and without polycystic ovary syndromeJ Womens Health (Larchmt)201625663864526871978
   PubMed Web of Science ®Google Scholar
• YildizBOApproach to the patient: contraception in women with polycystic ovary syndromeJ Clin Endocrinol Metab2015100379480225701301
   PubMed Web of Science ®Google Scholar
• EhrmannDAKaszaKAzzizRLegroRSGhazziMNEffects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndromeJ Clin Endocrinol Metab2005901667115507516
   PubMed Web of Science ®Google Scholar
• GambineriAPelusiCManicardiEGlucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factorsDiabetes20045392353235815331545
   PubMed Web of Science ®Google Scholar
• EhrmannDABarnesRBRosenfieldRLCavaghanMKImperialJPrevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndromeDiabetes Care199922114114610333916
   PubMed Web of Science ®Google Scholar
• SolomonCGHuFBDunaifALong or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitusJAMA2001286192421242611712937
   PubMed Web of Science ®Google Scholar
• GastG-CMGrobbeeDESmitHABueno-de-MesquitaHBSamsioeGNvan der SchouwYTMenstrual cycle characteristics and risk of coronary heart disease and type 2 diabetesFertil Steril20109462379238120451189
   PubMed Web of Science ®Google Scholar
• BrowerMBrennanKPallMAzzizRThe severity of menstrual dysfunction as a predictor of insulin resistance in PCOSJ Clin Endocrinol Metab20139812E1967E197124092831
   PubMed Web of Science ®Google Scholar
• EhrmannDASturisJByrneMMKarrisonTRosenfieldRLPolonskyKSInsulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitusJ Clin Invest19959615205277615824
   PubMed Web of Science ®Google Scholar
• DunaifAFinegoodDTBeta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndromeJ Clin Endocrinol Metab19968139429478772555
   PubMed Web of Science ®Google Scholar
• ArslanianSALewyVDDanadianKGlucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular diseaseJ Clin Endocrinol Metab2001861667111231980
   PubMed Web of Science ®Google Scholar
• GlintborgDHojlundKAndersenNRHansenBFBeck-NielsenHWojtaszewskiJFPImpaired insulin activation and dephosphorylation of glycogen synthase in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatmentJ Clin Endocrinol Metab20089393618362618544618
   PubMed Web of Science ®Google Scholar
• PierceGLZhuHDarracottKArterial stiffness and pulse-pressure amplification in overweight/obese African-American adolescents: relation with higher systolic and pulse pressureAm J Hypertens2013261202623382323
   PubMed Web of Science ®Google Scholar
• Manneras-HolmLLeonhardtHKullbergJAdipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistanceJ Clin Endocrinol Metab2011962E304E31121084397
   PubMed Web of Science ®Google Scholar
• SarraySMadanSSalehLRMahmoudNAlmawiWYValidity of adiponectin-to-leptin and adiponectin-to-resistin ratios as predictors of polycystic ovary syndromeFertil Steril2015104246046626051098
   PubMed Web of Science ®Google Scholar
• RepaciAGambineriAPasqualiRThe role of low-grade inflammation in the polycystic ovary syndromeMol Cell Endocrinol20113351304120708064
   PubMed Web of Science ®Google Scholar
• LuotolaKPiltonenTTPuurunenJTapanainenJSIL-1 receptor antagonist levels are associated with glucose tolerance in polycystic ovary syndromeClin Endocrinol (Oxf) Epub201647
   Web of Science ®Google Scholar
• Diamanti-KandarakisEPaterakisTAlexandrakiKIndices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metforminHum Reprod20062161426143116497699
   PubMed Web of Science ®Google Scholar
• KimJJChoiYMDyslipidemia in women with polycystic ovary syndromeObstet Gynecol Sci201356313714224327994
   PubMedGoogle Scholar
• RoeAHillmanJButtsSDecreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOSJ Clin Endocrinol Metab2014995E841E84724512495
   PubMed Web of Science ®Google Scholar
• GourgariELodishMShamburekRLipoprotein particles in adolescents and young women with PCOS provide insights into their cardiovascular riskJ Clin Endocrinol Metab2015100114291429826371381
   PubMed Web of Science ®Google Scholar
• LorenziGMBraffettBHArendsVLQuality control measures over 30 years in a multicenter clinical study: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) studyPLoS One20151011e014128626529311
   PubMed Web of Science ®Google Scholar
• SalleyKESWickhamEPCheangKIEssahPAKarjaneNWNestlerJEGlucose intolerance in polycystic ovary syndrome – a position statement of the Androgen Excess SocietyJ Clin Endocrinol Metab200792124546455618056778
   PubMed Web of Science ®Google Scholar
• HurdWWAbdel-RahmanMYIsmailSAAbdellahMASchmotzerCLSoodAComparison of diabetes mellitus and insulin resistance screening methods for women with polycystic ovary syndromeFertil Steril20119641043104721813121
   PubMed Web of Science ®Google Scholar
• VrbikovaJDvorakovaKGrimmichovaTPrevalence of insulin resistance and prediction of glucose intolerance and type 2 diabetes mellitus in women with polycystic ovary syndromeClin Chem Lab Med200745563964417484627
   PubMed Web of Science ®Google Scholar
• BarcellosCRRochaMPHayashidaSANeryMMarcondesJAPrevalence of abnormalities of glucose metabolism in patients with polycystic ovary syndromeArq Bras Endocrinol Metabol200751460160517684622
   PubMedGoogle Scholar
• PalmertMRGordonCMKartashovAILegroRSEmansSJDunaifAScreening for abnormal glucose tolerance in adolescents with polycystic ovary syndromeJ Clin Endocrinol Metab20028731017102311889155
   PubMed Web of Science ®Google Scholar
• Velling MagnussenLMummHAndersenMGlintborgDHemoglobin A1c as a tool for the diagnosis of type 2 diabetes in 208 premenopausal women with polycystic ovary syndromeFertil Steril20119651275128021982282
   PubMed Web of Science ®Google Scholar
• KimJJChoiYMChoYMPrevalence of elevated glycated hemoglobin in women with polycystic ovary syndromeHum Reprod20122751439144422357766
   PubMed Web of Science ®Google Scholar
• GollandIMVaughan WilliamsCAShaletSMMillionLHElsteinMLack of predictive value of HbA1 for impaired glucose tolerance in polycystic ovary syndromeGynecol Endocrinol1989332292352589107
   PubMed Web of Science ®Google Scholar
• LerchbaumESchwetzVGiulianiAObermayer-PietschBAssessment of glucose metabolism in polycystic ovary syndrome: HbA1c or fasting glucose compared with the oral glucose tolerance test as a screening methodHum Reprod20132892537254423756702
   PubMed Web of Science ®Google Scholar
• StovallDWBaileyAPPastoreLMAssessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndromeJ Womens Health (Larchmt)2011201374321194310
   PubMed Web of Science ®Google Scholar
• CiampelliMFulghesuAMCucinelliFImpact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndromeMetabolism199948216717210024076
   PubMed Web of Science ®Google Scholar